Evidence map›Paper›PMID 42374910›Full record

ArticleCurrent drug targets2026

Improving B-cell Linear Epitope Prediction

Bing Rao, Yuxuan Tang, Jun Hu, Hanin Alahmadi, Yaseer Alqahtani, Muhammad Arif, Tanvir Alam

Abstract read
PubMed Publisher
In one paragraph

Article in Current drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bing RaoSchool of Information and Electrical Engineering, Hangzhou City University, Hangzhou, 310015, China.
Yuxuan TangZhejiang University of Technology, College of Information Engineering, Hangzhou, 310023, China.
Jun HuZhejiang University of Technology, College of Information Engineering, Hangzhou, 310023, China.
Hanin AlahmadiDepartment of Computer Science, College of Computer Science and Engineering, Taibah University, Madinah, 344, Saudi Arabia.
Yaseer AlqahtaniIndependent Research in Health Science, Ministry of Health, Madinah, Saudi Arabia.
Muhammad ArifCollege of Science and Engineering, Hamad Bin Khalifa University, Doha 34110, Qatar.
Tanvir AlamCollege of Science and Engineering, Hamad Bin Khalifa University, Doha 34110, Qatar.

Funding

Fundamental Research Funds for the Provincial Universities of Zhejiang RF-A20200012National Natural Science Foundation of China 61902352, 62072243Natural Science Foundation of Zhejiang LY21F020025, LZ20F030002
6 · The paper itself

Abstract

introductionThe identification of linear B-Cell epitopes (BCEs) is significantly important for the discovery of drugs, such as antibody production, peptide-based vaccines, and other therapeutics. MATERIALS AND

methodsUnlike traditional laboratory-based methods, computational techniques can save cost and time in predicting large-scale BCEs. For this purpose, numerous in-silico methods have been designed to enhance the overall efficacy of BCE prediction. However, research gaps exist for further improvement in the context of using novel feature representations and learning models for BCE prediction. Therefore, in the present study, we aimed to design a novel sequence- based predictor named CoBCEs for screening and discriminating accurate BCEs. The proposed CoBCEs model incorporates the notion of graph-based signature, texture-based, and protein language model (pLM)-based features to sufficiently explore the local and global evolutionary information from protein sequences alone. Then, we fed the fused features, i.e., ProtVec sequence embeddings, Distance-Enhanced Graph (DE-Graph), and term frequency-inverse document frequency (TF-IDF), to an ensemble machine learning classifier.

resultsExperimental results of cross-validation and independent tests on several datasets demonstrate that CoBCEs attained superior performance in terms of accuracy, 77.3%, and Matthews correlation coefficient (MCC) of 61.8%, compared with other existing BCE predictors. DISCUSSION: Detailed data analyses show that the major advantage of CoBCEs lies in the combined utilization of graph-based and pLM-based features, which extract more discriminative information from sequences. In the future, we aim to develop a publicly available web server using biological language models for large-scale BCE peptide prediction.

conclusionWe believe our proposed approach will offer valuable insights for drug discovery and disease treatment.

Indexed as

Epitopes, B-LymphocyteMachine LearningAlgorithmsClassification AlgorithmsComputational BiologyHumansImmunoinformaticsPrediction AlgorithmsPredictive Learning ModelsEpitopes, B-LymphocyteB-cell epitopesdrug discoveryfeature selectionmachine learningprotein language model based features

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.